1,160
Total Claims
$476K
Drug Cost
224
Beneficiaries
$2,126
Cost/Patient
Peer Comparison vs. 8,961 Nephrology providers
+66%
Cost per patient vs peers
$2,126 vs $1,283 avg
+96%
Brand preference vs peers
17.6% vs 9.0% avg
Brand vs Generic
82% generic
Brand: 204 claims · $441K
Generic: 956 claims · $35K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Tolvaptan | 13 | $237K |
| Patiromer Calcium Sorbitex | 47 | $56K |
| Dapagliflozin Propanediol | 39 | $44K |
| Sucroferric Oxyhydroxide | 13 | $31K |
| Finerenone | 21 | $23K |
| Sevelamer Carbonate | 31 | $4,682 |
| Potassium Chloride | 21 | $3,332 |
| Metolazone | 45 | $3,207 |
| Cinacalcet Hcl | 12 | $2,709 |
| Chlorthalidone | 60 | $1,875 |
| Bumetanide | 30 | $1,181 |
| Labetalol Hcl | 11 | $1,178 |
| Furosemide | 99 | $1,065 |
| Amlodipine Besylate | 98 | $1,044 |
| Losartan Potassium | 50 | $993 |
Prescribing Profile
26
Unique Drugs
Patient Profile
74
Avg Age
62%
Female
3.14
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About